Featured Article

Important Role of Health Surveillance Systems in Community‐Based Colorectal Cancer Screening
Ann Chao, Sudha Sivaram
The Oncologist 2018; first published on July 26, 2018; doi:10.1634/theoncologist.2018-0178


The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451


Recent Translated Articles from The Oncologist


Volume 23: Number 10, October 2018


Clinical Trial Results

NGR-hTNF 和阿霉素作为小细胞肺癌患者二线治疗的疗效
NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
Vanesa Gregorc, Raffaele Cavina, Sivia Novello, Francesco Grossi, Chiara Lazzari, Enrica Capelletto, Carlo Genova, Giulia Salini, Antonio Lambiase, Armando Santoro
The Oncologist 2018; 23:1133-e112; first published on August 3, 2018; doi:10.1634/theoncologist.2018-0292

根据难治性恶性实体瘤患者的肿瘤组织激酶活性谱选择蛋白激酶抑制剂:介入式分子表达谱研究
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
Mariette Labots, Johannes C. Van der Mijn, Henk Dekker, Rita Ruijter, Thang V. Pham, Hans J. Van der Vliet, Jacobus J.M. Van der Hoeven, Gerrit A. Meijer, Henk M.W. Verheul
The Oncologist 2018; 23:1135-e118; first published on July 17, 2018; doi:10.1634/theoncologist.2018-0263


Breast Cancer

采用皮下注射曲妥珠单抗辅助治疗 HER2 阳性早期乳腺癌: SafeHer III 期研究体重的安全性和活跃医学疾病的亚组分析
Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study
Kyung Hae Jung, Beyhan Ataseven, Mark Verrill, Xavier Pivot, Michelino De Laurentiis, Nedal Al‐Sakaff, Sabine Lauer, Mona Shing, Joseph Gligorov, Hamdy A. Azim
The Oncologist 2018; 23:1137-1143; first published on July 17, 2018; doi:10.1634/theoncologist.2018-0065

转移性三阴性乳腺癌患者治疗前18F-FDG摄取异质性预测一线化疗疗效
Pretreatment 18F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer
Chengcheng Gong, Guang Ma, Xichun Hu, Yingjian Zhang, Zhonghua Wang, Jian Zhang, Yannan Zhao, Yi Li, Yizhao Xie, Zhongyi Yang, Biyun Wan
The Oncologist 2018; 23:1144-1152; first published on August 6, 2018; doi:10.1634/theoncologist.2018-0001

蒽环类辅助疗法在乳腺癌中的使用:它们具有什么作用?
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
Ami N. Shah, William J. Gradishar
The Oncologist 2018; 23:1153-1161; first published on August 17, 2018; doi:10.1634/theoncologist.2017-0672


Gastrointestinal Cancer

胃癌和胃食管交界部腺癌的免疫肿瘤学生物标志物:为何 PD-L1检测可能并未足够
Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough
Benjamin A. Weinberg, Joanne Xiu, Jimmy J. Hwang, Anthony F. Shields, Mohamed E. Salem, John L. Marshall
The Oncologist 2018; 23:1171-1177; first published on April 27, 2018; doi:10.1634/theoncologist.2018-0034

Trifluridine/Tipiracil (TAS-102)在难治型转移性结直肠癌中的应用:意大利同情使用计划框架下的多中心登记
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program
Chiara Cremolini, Daniele Rossini, Erika Martinelli, Filippo Pietrantonio, Sara Lonardi, Silvia Noventa, Emiliano Tamburini, Giovanni Luca Frassineti, Stefania Mosconi, Federico Nichetti, Sabina Murgioni, Teresa Troiani, Beatrice Borelli, Gemma Zucchelli, Alessandro Dal Maso, Vincenzo Sforza, Gianluca Masi, Carlotta Antoniotti, Maria Di Bartolomeo, Rosalba Miceli, Fortunato Ciardiello, Alfredo Falcone
The Oncologist 2018; 23:1178-1187; first published on May 8, 2018; doi:10.1634/theoncologist.2017-0573


Global Health and Cancer

生物仿制药的全球接受情况:监管一致性、教育和信任的重要性
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust
Eduardo Cazap, Ira Jacobs, Ali McBride, Robert Popovian, Karol Sikora
The Oncologist 2018; 23:1188-1198; first published on May 16, 2018; doi:10.1634/theoncologist.2017-0671


Lung Cancer

表皮生长因子受体酪氨酸激酶抑制剂用于非小细胞肺癌中枢神经系统转移
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer
Manmeet S. Ahluwalia, Kevin Becker, Benjamin P. Levy
The Oncologist 2018; 23:1199-1209; first published on April 12, 2018; doi:10.1634/theoncologist.2017-0572

晚期胸腺癌患者一线化疗预后因素及疗效分析:NEJ023 研究中 286 例患者回顾性分析
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study
Ryo Ko, Takehito Shukuya, Yusuke Okuma, Kazunari Tateishi, Hisao Imai, Shunichiro Iwasawa, Eisaku Miyauchi, Akiko Fujiwara, Tomohide Sugiyama, Keisuke Azuma, Keiko Muraki, Masahiro Yamasaki, Hisashi Tanaka, Yuta Takashima, Sayo Soda, Osamu Ishimoto, Nobuyuki Koyama, Satoshi Morita, Kunihiko Kobayashi, Toshihiro Nukiwa, Kazuhisa Takahashi, North East Japan Study Group
The Oncologist 2018; 23:1210-1217; first published on March 22, 2018; doi:10.1634/theoncologist.2017-0586


Symptom Management and Supportive Care

晚期肺癌患者及其照料者对诊断及相关因素的预后认知
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers
Takashi Sato, Kenzo Soejima, Daisuke Fujisawa, Mari Takeuchi, Daisuke Arai, Ichiro Nakachi, Katsuhiko Naoki, Ichiro Kawada, Hiroyuki Yasuda, Kota Ishioka, Shigenari Nukaga, Keigo Kobayashi, Katsunori Masaki, Takashi Inoue, Kota Hikima, Morio Nakamura, Keiko Ohgino, Yoshitaka Oyamada, Yohei Funatsu, Takeshi Terashima, Naoki Miyao, Koichi Sayama, Fumitake Saito, Fumio Sakamaki, Tomoko Betsuyaku
The Oncologist 2018; 23:1218-1229; first published on August 17, 2018; doi:10.1634/theoncologist.2017-0329